ARMATA PHARMACEUTICALS, INC. Finite-Lived Patents, Gross
ARMATA PHARMACEUTICALS, INC. (ARMP) had Finite-Lived Patents, Gross of $361.00 thousand as of 2015-03-31, per its 10-Q filed 2015-05-15.
Discontinued › Balance Sheet › Assets › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedPatentsGross · last filed 2015-05-15
- 2015-03-31: Finite-Lived Patents, Gross $361.00K.
- 2014-12-31: Finite-Lived Patents, Gross $369.00K.
- 2014-09-30: Finite-Lived Patents, Gross $377.00K.
- 2014-06-30: Finite-Lived Patents, Gross $385.00K.
| Period end | Finite-Lived Patents, Gross |
|---|---|
| 2015-03-31 | $361.00K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $369.00K 10-Q · filed 2015-05-15 |
| 2014-09-30 | $377.00K 10-Q/A · filed 2015-04-15 |
| 2014-06-30 | $385.00K 10-Q/A · filed 2015-04-15 |
| 2014-03-31 | $392.00K 10-Q/A · filed 2015-04-15 |
| 2013-12-31 | $400.00K 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |